Increase in incidence of resistance to ampicillin. Chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance

Journal of Medical Microbiology

Volumn 48, Issue 4, 1999, Pages 367-374

  Gallardo, F ^a   Ruiz, J ^a   Marco, F ^a   Towner, K J ^b   Vila, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CHLORAMPHENICOL; CHLORAMPHENICOL ACETYLTRANSFERASE; COTRIMOXAZOLE; DIHYDROFOLATE REDUCTASE; NORFLOXACIN; QUINOLONE DERIVATIVE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVITY; EPIDEMIOLOGY; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLIC HEALTH; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; SALMONELLA TYPHIMURIUM;

EID: 0032835483     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-4-367     Document Type: Article

References (57)

1. Miller SI, Hohmann EL, Pegues DA. Salmonella (including Salmonella typhi). In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett's Principles and practice of infectious diseases, vol. 2, 4th edn. 1995. New York, Churchill Livingstone. 1995: 2013-2033.
2. Hook EW. Salmonellosis: certain factors influencing the interaction of Salmonella and the human host. Bull NY Acad Med 1961; 37: 499-512.
3. Glaser JB, Morton-Kute L, Berger SR et al. Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102: 189-193.
4. Cohen ML, Tauxe RV. Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science 1986; 234: 964-969.
5. Duguid JP, Anderson ES. Alfredsson GA, Barker R, Old DC. A new biotyping scheme for Salmonella typhimurium and its phylogenetic significance. J Med Microbiol 1975; 8: 149-166.
6. Anderson ES, Ward LR, de Saxe MJ, de Saxe JDH. Bacteriophage-typing designations of Salmonella typhimurium. J Hyg 1977; 78: 297-300.
7. Guinée PAM, Jansen WH, van Schuylenberg A, van Leeuwen WJ. Bacteriophage typing of Salmonella typhimurium by use of a mechanized technique. Appl Microbiol 1973: 26: 474-477.
8. Anderson ES. Drug resistance in Salmonella typhimurium and its implications. BMJ 1968; 3: 333-339.
9. Brunner F, Margadant A, Peduzzi R, Piffaretti JC. The plasmid pattern as an epidemiologic tool for Salmonella typhimurium epidemics: comparison with the lysotype. J Infect Dis 1983; 148: 7-11.
10. Taylor DN, Wachsmuth IK, Shangkuan Y-H et al. Salmonellosis associated with marijuana. A multistate outbreak traced by plasmid fingerprinting. N Engl J Med 1982; 306: 1249-1253.
11. Kapperud G, Lassen J, Dommarsnes K et al. Comparison of epidemiological marker methods for identification of Salmonella typhimurium isolates from an outbreak caused by contaminated chocolate. J Clin Microbiol 1989; 27: 2019-2024.
12. Platt DJ, Brown DJ, Old DC, Barker RM, Munro DS, Taylor, J. Old and new techniques together resolve a problem of infection by Salmonella typhimurium. Epidemiol Infect 1987; 99: 137-142.
13. Threlfall EJ, Frost JA. The identification, typing and finger-printing of Salmonella: laboratory aspects and epidemiological applications. J Appl Bacteriol 1990; 68: 5-16.
14. Nastasi A, Mammina C. Epidemiological evaluation by PCR ribotyping of sporadic and outbreak-associated strains of Salmonella enterica serotype typhimurium. Res Microbiol 1995; 146: 99-106.
15. Stanley J, Baquar N, Threlfall EJ. Genotypes and phylogenetic relationships of Salmonella typhimurium are defined by molecular fingerprinting of IS200 and 16S rrn loci. J Gen Microbiol 1993; 139: 1133-1140.
16. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken FC (eds). Manual of clinical microbiology, 6th edn. Washington, DC, ASM. 1995.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. M2-A4, 4th edn. Villanova, PA, National Committee for Clinical Laboratory Standard. 1990.
18. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd edn. Approved standard M7-A2. Villanova, PA. National Committee for Clinical Laboratory Standard. 1990.
19. O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283-288.
20. Arlet G, Philipon A. Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV CARB). FEMS Microbiol Lett 1991; 82: 19-26.
21. Robison LR, Seligsohn R, Lerner SA. Simplified radioenzymatic assay for chloramphenicol. Antimicrob Agents Chemother 1978; 13: 25-29.
22. Azemun P, Stull T, Roberts M, Smith AL. Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother 1981; 20: 168-170.
23. Maniatis T, Fritsch EF, Sambrook J. In: Molecular cloning: a laboratory manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory. 1982: 314.
24. Heikkila E, Sundström L, Skurnik M, Huovinen P. Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland. Antimicrob Agents Chemother 1991; 35: 1562-1569.
25. Carter GI, Towner KJ, Slack RCB. Detection of TEM beta-lactamase genes by non-isotopic spot hybridisation. Eur J Clin Microbiol 1987; 6: 406-409.
26. Matushek MG, Bonten MJM, Hayden MK. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J Clin Microbiol 1996; 34: 2598-2600.
27. Marcos MA, Jimenez de Anta MT, Vila J. Correlation of six methods for typing nosocomial isolates of Acinetobacter baumannii. J Med Microbiol 1995; 42: 328-335.
28. Vila J, Marcos MA, Jimenez de Anta MT. A comparative study of different PCR-bascd DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus - A. baumannii complex. J Med Microbiol 1996; 44: 482-489.
29. Blaser MJ, Feldman RA. Salmonella bacteremia: Reports of the Centers for Diseases Control, 1968-1979. J Infect Dis 1981; 143: 743-746.
30. Bottone EJ, Wormser GP, Duncanson FP. Nontyphoidal salmonella bacteremia as an early infection in the acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 1984; 2: 247-250.
31. Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DF. Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987; 156: 998-1002.
32. Cherubin CE, Neu HC, Imperato PJ, Harvey RP, Bellen N. Septicemia with non-typhoid salmonella. Medicine 1974; 53: 365-376.
33. Sperber SJ, Schleupner CJ. Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis 1987; 9: 925-934.
34. Smith PD, Macher AM, Bookman MA et al. Salmonella typhimurium enteritis and bacteremia in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102: 207-209.
35. Alós JI, Gómez Garćes JL, Cogollos R, Amor E, Pérez-Rivilla A. Susceptibilities of ampicillin-resistant strains of Salmonella other than S. typhi to 10 antimicrobial agents. Antimicrob Agents Chemother 1992; 36: 1794-1796.
36. Muñuz P, Díaz MD, Rodriguez-Créixems M, Cercenado E, Peláz T, Bouza E. Antimicrobial resistance of Salmonella isolates in a Spanish hospital. Antimicrob Agents Chemother 1993; 37: 1200-1202.
37. Ramos JM, Alés JM, Cuenca-Estrella M, Fernandez-Roblas R, Soriano F. Changes in susceptibility of Salmonella enteritidis, Salmonella typhimurium, and Salmonella virchow to six antimicrobial agents in a Spanish hospital, 1980-1994. Eur J Clin Microbiol Infect Dis 1996; 15: 85-88.
38. Reina J, Gomez J, Serra A, Borell N. Analysis of the antibiotic resistance detected in 2043 strains of Salmonella enterica subsp. enterica isolated in stool cultures of Spanish patients with acute diarrhoea (1986-1991). J Antimicrob Chemother 1993, 32: 765-769.
39. Lee LA, Puhr ND, Maloney EK, Bean NH, Tauxe RV. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis 1994; 170: 128-134.
40. Ward LR, Threlfall EJ, Rowe B. Multiple drug resistance in salmonellae in England and Wales: a comparison between 1981 and 1988. J Clin Pathol 1990; 43: 563-566.
41. Liu PYF, Gur D, Hall LMC, Livermore DM. Survey of the prevalence of β-lactamasE amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30: 429-447.
42. Roy C, Foz A, Segura C, Tirado M, Fuster C, Reig R. Plasmid-determined β-lactarnases identified in a group of 204 ampicillin-resistant Enterobacteriaceae. J Antimicrob Chemother 1983; 12: 507-510.
43. Medeiros AA, Hedges RW, Jacoby GA. Spread of a "Pseudomonas-specific" β-lactamase to plasmids of enterobacteria. J Bacteriol 1982; 149: 700-707.
44. Dale JW, Godwin D, Mossakowska D, Stephenson P, Wall S. Sequence of the OXA-2 β-lactamase: comparison with other penicillin-reactive enzymes. FEBS Lett 1985; 191: 39-44.
45. Toro CS, Lobos SR, Calderón I, Rodriguez M, Mora GC. Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob Agents Chemother 1990; 34: 1715-1719.
46. Amyes SGB. The success of plasmid-encoded resistance genes in clinical bacteria. J Med Microbiol 1989; 28: 73-83.
47. Goldstein FW, Papadopoulou B, Acar JF. The changing pattern of trimethoprim resistance in Paris with a review of worldwide experience. Rev Infect Dis 1986; 8: 725-737.
48. Agodi A, Marranzano M, Jones CS, Threlfall EJ. Molecular characterization of trimethoprim resistance in salmonellas isolated in Sicily, 1985-1988. Eur J Epidemiol 1995; 11: 33-38.
49. Brown JC, Thomson CJ, Amyes SGB. Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs. J Antimicrob Chemother 1996; 37: 351-356.
50. Hof H, Ehrhard I, Tschape H. Presence of quinolone resistance in a strain of Salmonella typhimurium. Eur J Clin Microbiol Infect Dis 1991; 10: 747-749.
51. Ruiz J, Castro D, Goñi P. Santamaria JA, Borrego JJ, Vila J. Analysis of the mechanism of quinolone resistance in nalidixie acid-resistant clinical isolates of Salmonella serotype Typhimurium. J Med Microbiol 1997; 46: 623-628.
52. Hirai K, Aoyama H, Irikura T, Iyobe S, Mitsuhashi S. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother 1986; 29: 535-538.
53. Garbarg-Chenon A, Godard V, Labia R, Nicolas J-C. Nucleotide sequence of SHV-2 β-lactamase gene. Antimicrob Agents Chemother 1990; 34: 1444-1446.
54. Vu Thien H, Baudon JJ, Rolland M. Salmonella typhimurium: resistance aux céphalospoorines de troisième génération. Med Mal Infect 1987; 6/7: 398-400.
55. Wall PG, Morgan D, Lamden K et al. A case-control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT 104 in England and Wales. Commun Dis Rep CDR Rev 1994; 4: R130-135.
56. Murase T, Okitsu T, Suzuki R et al. Evaluation of DNA fingerprinting by PFGE as an epidemiologic tool for Salmonella infections. Microbiol Immunol 1995; 39: 673-676.
57. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991; 19: 6823-6831.